LEADS BIOLABS-B (09887): Trustee purchases 220,700 H shares under the H-share award scheme

date
12:32 17/11/2026
avatar
GMT Eight
LEADS BIOLABS-B (09887) announced that on November 16, 2026, the trustee purchased 220,700 H shares (Share Purchase) on The Stock Exchange of Hong Kong Limited under the H-share award scheme, at a total consideration of HK$7.3726 million.
LEADS BIOLABS-B (09887) announced that on November 16, 2026, the trustee purchased 220,700 H shares on The Stock Exchange of Hong Kong Limited under the H-share award scheme (the share purchase), for a total consideration of HK$7.3726 million. The Company may continue to instruct the trustee to purchase H shares through open market transactions in accordance with the rules of the H-share award scheme. The Board believes that the share purchase demonstrates the Company's confidence in its business outlook and prospects, and will bring long-term benefits to the Company and enhance shareholder value. The Board further believes that the Company has sufficient financial resources to implement the share purchase while maintaining a sound financial position.